VERA

Vera Therapeutics, Inc.

Healthcare · Biotechnology

$284.63 sample

-2.65 (-0.92%) 1D

Market cap

$475.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-07

Alerts

8

Price$284.63 +7.21% 3M daily closessample

288.81258.91

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: EVP, Operations
Oct 06INSInsider sell: EVP, Operations
Oct 01INSInsider sell: Chief Executive Officer
Sep 24INSInsider sell: Director
Sep 16INSInsider buy: General Counsel
Sep 07SECForm 144 filed
Aug 31INSInsider sell: Chief Financial Officer
Aug 21SECDEF 14A filed

Sign up to see the real VERA record →

Company facts

SEC EDGAR registration

Name: Vera Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +36sample, -100 to +100
Reporting currency: USD

Who is positioning in VERA

sample

Insiders: 25 insider transactions over 90 days, net selling, $763.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 41 funds hold $11.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$13.1B +13.1% y/y

Q4 2024Q3 2026

Inventory$7.5B +11.9% y/y

Q4 2024Q3 2026

Accounts receivable$5.7B +5.6% y/y

Q4 2024Q3 2026

Total debt$15.8B +10.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $219.9B -3.6% 3M
Sample peer B: $329.7B +10.7% 3M
Sample peer C: $243.2B -11.9% 3M
Sample peer D: $386.4B +8.6% 3M
Sample peer E: $87.4B +7.4% 3M